- Home
- GRNT vs CGEM Comparison
GRNT vs CGEM Comparison
Compare GRNT & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRNT
- CGEM
- Stock Information
- Founded
- GRNT 2013
- CGEM 2016
- Country
- GRNT United States
- CGEM United States
- Employees
- GRNT N/A
- CGEM N/A
- Industry
- GRNT Blank Checks
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- GRNT Finance
- CGEM Health Care
- Exchange
- GRNT Nasdaq
- CGEM Nasdaq
- Market Cap
- GRNT 856.4M
- CGEM 730.2M
- IPO Year
- GRNT N/A
- CGEM 2021
- Fundamental
- Price
- GRNT $6.03
- CGEM $12.27
- Analyst Decision
- GRNT Buy
- CGEM Strong Buy
- Analyst Count
- GRNT 3
- CGEM 7
- Target Price
- GRNT $7.60
- CGEM $31.67
- AVG Volume (30 Days)
- GRNT 761.5K
- CGEM 520.5K
- Earning Date
- GRNT 11-07-2024
- CGEM 11-07-2024
- Dividend Yield
- GRNT 7.31%
- CGEM N/A
- EPS Growth
- GRNT N/A
- CGEM N/A
- EPS
- GRNT 0.36
- CGEM N/A
- Revenue
- GRNT $358,521,000.00
- CGEM N/A
- Revenue This Year
- GRNT $4.66
- CGEM N/A
- Revenue Next Year
- GRNT $22.97
- CGEM N/A
- P/E Ratio
- GRNT $16.71
- CGEM N/A
- Revenue Growth
- GRNT N/A
- CGEM N/A
- 52 Week Low
- GRNT $5.20
- CGEM $9.24
- 52 Week High
- GRNT $7.10
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- GRNT 46.96
- CGEM 45.60
- Support Level
- GRNT $5.47
- CGEM $10.44
- Resistance Level
- GRNT $6.30
- CGEM $12.79
- Average True Range (ATR)
- GRNT 0.23
- CGEM 0.68
- MACD
- GRNT -0.02
- CGEM 0.09
- Stochastic Oscillator
- GRNT 65.12
- CGEM 57.91
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.